Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04587063 · ClinicalTrials.gov registry record · NA
Evaluation of Emails Promoting Mail-order Pharmacy
A NA study of Health Care Utilization, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 5,266
- Enrollment target
- 1
- Study location
NCT04587063: Completed NA study of Health Care Utilization, sponsored by Geisinger Clinic.
NCT04587063 is a NA study of Health Care Utilization that has completed, run by Geisinger Clinic. The registered enrollment target is 5,266 participants, above the 711-participant average among 25 other Health Care Utilization trials with a reported enrollment target (641% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04587063, a NA study of Health Care Utilization, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,266 participants
- Enrollment target
- 1
- Study location
Study Summary
In this evaluation, four versions of emails will be sent to eligible health plan members who are not currently enrolled in the health system's mail-order pharmacy. A control group will not receive any communication. The researchers hypothesize that the use of content informed by behavioral nudge theory in the emails should lead to increased enrollment in the health system's mail-order pharmacy.
Primary Outcome
Binary variable indicating if there was an enrollment in the health system's mail order pharmacy
Conditions Studied
Interventions
- BEHAVIORAL Fear Appeals
- BEHAVIORAL Message about Future Healthcare Costs
- BEHAVIORAL Endorsement from a Doctor
- BEHAVIORAL Comparison Table
- BEHAVIORAL Highlighting Cost Savings and Convenience
Study Locations (1)
Pennsylvania
- Geisinger - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,266 participants |
| Start Date | 2020-10-13 |
| Est. Completion | 2020-10-20 |
| Phase | NA |
What the finished NCT04587063 record still lists
NCT04587063 is an interventional study that assigns participants to a tested intervention. Its 5,266 participants enrollment target places it among the larger protocols in the corpus, above the 711-participant average among 25 other Health Care Utilization trials with a reported enrollment target (641% higher).
The record links to 1 condition, with Health Care Utilization appearing as the primary indexed condition, and to 5 interventions - of which Fear Appeals is the first listed.
NCT04587063 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04587063 about?
NCT04587063 is a clinical study titled "Evaluation of Emails Promoting Mail-order Pharmacy". In this evaluation, four versions of emails will be sent to eligible health plan members who are not currently enrolled in the health system's mail-order pharmacy. A control group will not receive any communication. The researchers hypothesize that the use of content informed by behavioral nudge the...
What is the current status of trial NCT04587063?
This trial is currently completed. It is a NA study. The enrollment target is 5,266 participants. The study started on 2020-10-13. Estimated completion is 2020-10-20.
What conditions does trial NCT04587063 study?
This clinical trial studies the following conditions: Health Care Utilization.
What interventions are being tested in trial NCT04587063?
The interventions under investigation include: Fear Appeals (BEHAVIORAL), Message about Future Healthcare Costs (BEHAVIORAL), Endorsement from a Doctor (BEHAVIORAL), Comparison Table (BEHAVIORAL), Highlighting Cost Savings and Convenience (BEHAVIORAL).
Who is sponsoring clinical trial NCT04587063?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04587063 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Care Utilization
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04587063's enrollment target sits among peer trials
5,266 1st of 25 higher than 25 of 25 other Health Care Utilization trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Health Care Utilization trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
UCSD RELINK: Connecting Adults To Supportive Services
RECRUITING · NA
-
ACP Video Intervention for Patients With Life-Limiting Illness
RECRUITING · NA
-
Evaluation of a Health System Integrated Model for Postpartum Education and Support in Rural Populations
RECRUITING · NA
-
Fresh RX: NHS 2020
RECRUITING · NA
-
Universal Basic Income and Structural Racism in the US South: HIV Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06506344 · 5,250 participants · NA
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
- NCT05373771 · 5,328 participants · NA
Sickle Cell Improvement: Enhancing Care in the Emergency Department
- NCT05989308 · 5,200 participants · NA
MyChart Proxy Outreach to Parents (MyPOP)
- NCT06008197 · 5,200 participants · Phase 3
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI